Periodic Reporting for period 2 - VASA (Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa)

The VASA project addresses the overall objective of bridging the gap between preclinical and early clinical development of vaccines against schistosomiasis, one of the highest burden neglected parasitic disease in sub-Saharan Africa (sSA). Schistosomiasis is a poverty-related...